Terms: = Breast cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Diagnosis
38 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Biological basis of extensive pleiotropy between blood traits and cancer risk.
Pardo-Cea MA; Farré X; Esteve A; Palade J; Espín R; Mateo F; Alsop E; Alorda M; Blay N; Baiges A; Shabbir A; Comellas F; Gómez A; Arnan M; Teulé A; Salinas M; Berrocal L; Brunet J; Rofes P; Lázaro C; Conesa M; Rojas JJ; Velten L; Fendler W; Smyczynska U; Chowdhury D; Zeng Y; He HH; Li R; Van Keuren-Jensen K; de Cid R; Pujana MA
Genome Med; 2024 Feb; 16(1):21. PubMed ID: 38308367
[TBL] [Abstract] [Full Text] [Related]
3. Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing.
Schwartz CJ; Krings G; Chen YY
Histopathology; 2024 Jan; 84(2):409-411. PubMed ID: 37706238
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value and immune landscapes of tert promoter methylation in triple negative breast cancer.
Lin F; Huang J; Zhu W; Jiang T; Guo J; Xia W; Chen M; Guo L; Deng W; Lin H
Front Immunol; 2023; 14():1218987. PubMed ID: 37575241
[TBL] [Abstract] [Full Text] [Related]
5. Mutational profiling of Chinese patients with thyroid cancer.
Du Y; Zhang S; Zhang G; Hu J; Zhao L; Xiong Y; Shen L; Chen R; Ye K; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1156999. PubMed ID: 37465126
[TBL] [Abstract] [Full Text] [Related]
6. [Pathological features and clinicopathological significance of tert promoter mutation in breast fibroepithelial tumors without definite diagnosis].
Wang JG; Hu YJ; Guan JJ; Liu HY; Bi ZJ; Zhang LX; Liu YX; Xing XM
Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):153-159. PubMed ID: 36748136
[No Abstract] [Full Text] [Related]
7. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review.
Lei T; Shi YQ; Chen TB
Diagn Pathol; 2023 Feb; 18(1):13. PubMed ID: 36737820
[TBL] [Abstract] [Full Text] [Related]
8. Frequency of tert Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.
Yang H; Park H; Ryu HJ; Heo J; Kim JS; Oh YL; Choe JH; Kim JH; Kim JS; Jang HW; Kim TH; Kim SW; Chung JH
Endocrinol Metab (Seoul); 2022 Aug; 37(4):652-663. PubMed ID: 35864728
[TBL] [Abstract] [Full Text] [Related]
9. Clinical implications of lipid peroxides levels in plasma and tumor tissue in breast cancer patients.
Scandolara TB; da Silva JC; Alves FM; Malanowski J; de Oliveira ST; Maito VT; Rech D; Panis C; Bonvicino C
Prostaglandins Other Lipid Mediat; 2022 Aug; 161():106639. PubMed ID: 35550168
[TBL] [Abstract] [Full Text] [Related]
10. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
[TBL] [Abstract] [Full Text] [Related]
11. High-Grade Spindle Cell Lesions of the breast: Key Pathologic and Clinical Updates.
Yoon E; Ding Q; Hunt K; Sahin A
Surg Pathol Clin; 2022 Mar; 15(1):77-93. PubMed ID: 35236635
[TBL] [Abstract] [Full Text] [Related]
12. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
[TBL] [Abstract] [Full Text] [Related]
13. A Golgi Apparatus-Targeting, Naphthalimide-Based Fluorescent Molecular Probe for the Selective Sensing of Formaldehyde.
Fortibui MM; Lim W; Lee S; Park S; Kim J
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443565
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer-related single-nucleotide polymorphism and their risk contribution in Mexican women.
Figueroa-González G; Arellano-Gutiérrez CV; Cortés H; Leyva-Gómez G; Carmen MG; Bustamante-Montes LP; Rodríguez-Morales M; López-Reyes I; Alcaraz-Estrada SL; Sandoval-Basilio J; Quintas-Granados LI; Reyes-Hernández OD
J Cancer Res Ther; 2020; 16(6):1279-1286. PubMed ID: 33342785
[TBL] [Abstract] [Full Text] [Related]
15. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Cairo S; Armengol C; Maibach R; Häberle B; Becker K; Carrillo-Reixach J; Guettier C; Vokuhl C; Schmid I; Buendia MA; Branchereau S; von Schweinitz D; Kappler R
Eur J Cancer; 2020 Dec; 141():30-39. PubMed ID: 33125945
[TBL] [Abstract] [Full Text] [Related]
16. Fibromatosis-like metaplastic carcinoma: a case report and review of the literature.
Victoor J; Bourgain C; Vander Borght S; Vanden Bempt I; De Rop C; Floris G
Diagn Pathol; 2020 Mar; 15(1):20. PubMed ID: 32127014
[TBL] [Abstract] [Full Text] [Related]
17. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.
Corona G; Goulis DG; Huhtaniemi I; Zitzmann M; Toppari J; Forti G; Vanderschueren D; Wu FC
Andrology; 2020 Sep; 8(5):970-987. PubMed ID: 32026626
[TBL] [Abstract] [Full Text] [Related]
18.
Chang HY; Koh VCY; Md Nasir ND; Ng CCY; Guan P; Thike AA; Teh BT; Tan PH
J Clin Pathol; 2020 Jan; 73(1):51-56. PubMed ID: 31662438
[TBL] [Abstract] [Full Text] [Related]
19. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract] [Full Text] [Related]
20. tert Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
Stenman A; Hysek M; Jatta K; Bränström R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
Endocr Pathol; 2019 Sep; 30(3):246-248. PubMed ID: 31154561
[TBL] [Abstract] [Full Text] [Related]
[Next]
